Health benefits of a COMmunity-based WALKing programme in Bahraini adults with type 2 diabetes

Completed

• Conditions: Type 2 diabetes; Nutritional, Metabolic, Endocrine; Non-insulin-dependent diabetes mellitus

• Registration Number: ISRCTN49941929
• Lead Sponsor: Arabian Gulf University (Bahrain)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-06-21
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

1. Bahraini adults (aged 24-60 years) with type 2 diabetes (as defined by the American Diabetic Association, 1997) for more than 6 months
2. A baseline haemoglobin A1c of 6.6% to 9.9%.

Exclusion Criteria

1. Current insulin therapy
2. Participation in exercise two or more times per week for more than or equal to 20 minutes/session during the previous 6 months
3. Changes during the previous 2 months in oral hypoglycaemic, antihypertensive or lipid-lowering agents and body weight (more than or equal to 5%)
4. Serum creatinine level of 200 µmol/L or greater
5. Proteinuria greater than 1g/d
6. Blood pressure greater than 160/95 mm Hg
7. Restrictions in physical activity because of disease
8. Presence of other medical conditions that make participation inadvisable

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in haemoglobin A1c between baseline and the end of the 12-week programme

Secondary Outcome Measures

Name	Time	Method
1. Pedometry (steps/day)<br>2. Physical activity level (International Physical Activity Questionnaire) <br>3. Fraction of nitric oxide in exhaled air (FeNO) to evalaute cardiorespiratory fitness<br>4. Body Mass Index<br>5. Percent body fat<br>6. Blood glucose <br>Assessed at baseline, 6 and 12 weeks